AWHL Aspira Women's Health Inc.
Price Chart
Executive Summary
Aspira Women's Health Inc. filed definitive additional proxy soliciting materials (DEFA14A) for its 2026 Annual Meeting scheduled for June 17, 2026. The filing is a routine notice of the availability of proxy materials and lists four standard proposals: election of six director nominees, advisory vote on executive compensation, approval of an amendment to the 2019 Stock Incentive Plan, and ratification of BDO USA PC as independent auditor. The board recommends a 'For' vote on all items. No dissident or activist activity is indicated in the filing itself, though cross-filing actuarial verdicts flag amplifier patterns for dissident-proxy contexts, suggesting potential activist involvement in related filings.
Actionable Insight
Monitor for any dissident proxy materials or activist filings that may emerge ahead of the June 17 meeting, as cross-filing patterns suggest potential activist involvement. The stock plan amendment (Proposal 3) could lead to future dilution — review the full proxy statement for share reserve details.
Key Facts
- Annual Meeting scheduled for June 17, 2026 at 8:00 AM CT in Houston, TX
- Voting deadline is June 16, 2026 at 10:59 PM CT
- Six director nominees: Ellen Beausang, Jeffrey Cohen M.D., John Fraser, Cynthia Hundorfean, Winfred Parnell M.D., Jane Pine Wood
- Board recommends 'For' on all four proposals: director election, say-on-pay, stock plan amendment, auditor ratification
- Proposal 3 seeks approval to amend the 2019 Stock Incentive Plan
- BDO USA PC proposed as independent auditor for fiscal year ending December 31, 2026
- Cross-filing actuarial verdicts show statistically significant amplifier patterns for dissident-proxy contexts, suggesting possible activist involvement in related filings
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- Potential activist campaign or dissident proxy contest not yet fully disclosed
- Stock plan amendment could result in shareholder dilution if approved
- OTC-listed stock with low liquidity may see volatility around meeting date
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0000926617-26-000025 |
| Document: 0000926617-26-000025-index-headers.html | 0000926617-26-000025 |
| Document: 0000926617-26-000025-index.html | 0000926617-26-000025 |
| Document: 0000926617-26-000025.txt | 0000926617-26-000025 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
today
|
8-K
| $0.4341 awaiting T+5 | awaiting T+5 | — | $0.4000 (+7.86%) |
|
May 29, 2026
11d ago
|
Insider Cluster
| $0.5400 $0.4200 | ▼ −22.22% | ▼ −19.47% | $0.4000 (−25.93%) |
|
May 26, 2026
14d ago
|
8-K
| $0.4600 $0.5400 | ▲ +17.39% | ▲ +16.31% | $0.4000 (−13.04%) |
|
Apr 30, 2026
5w ago
|
8-K
| $0.3900 $0.4300 | ▲ +10.26% | ▲ +7.91% | $0.4000 (+2.56%) |
|
Apr 28, 2026
6w ago
|
DEFA14A
| $0.4000 $0.3900 | ▼ −2.50% | ▼ −5.61% | $0.4000 (+0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access